2017
DOI: 10.1371/journal.pone.0178173
|View full text |Cite
|
Sign up to set email alerts
|

Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer

Abstract: AimsThere is good evidence that the tumor microenvironment plays an important role in cancer metastasis and progression. Our previous studies have shown that brain-derived neurotrophic factor (BDNF) participates in the process of metastasis and in the migration of cancer cells. The aim of this study was to investigate the role of BDNF on the tumor cell microenvironment, namely, the cancer cell-endothelial cell interaction of TNBC cells.MethodsWe conducted oligoneucleotide microarray analysis of potential bioma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 38 publications
(22 citation statements)
references
References 43 publications
1
19
0
Order By: Relevance
“…As NT-3 and its TrkC receptor were observed during formation of HO ( Figure 2), thus we tried to further explore role of NT-3 on the induction of EndMT in HO. GNF5837, the inhibitor of TrkC receptor 25 Figure 7C, 7), which was similar with the effect of Dorsomorphin.…”
Section: Inhibition Of Nt-3 Suppressed the Induction Of Endmt And Bsupporting
confidence: 70%
“…As NT-3 and its TrkC receptor were observed during formation of HO ( Figure 2), thus we tried to further explore role of NT-3 on the induction of EndMT in HO. GNF5837, the inhibitor of TrkC receptor 25 Figure 7C, 7), which was similar with the effect of Dorsomorphin.…”
Section: Inhibition Of Nt-3 Suppressed the Induction Of Endmt And Bsupporting
confidence: 70%
“…Due to their great importance during metastasis development, targeting these proteases has been considered an important objective of anti-tumoral therapy, resulting in the development of a great variety of MMP inhibitors (reviewed in [278]). In this context, it has been shown by ingenuity pathway analysis that the BDNF/TrkA (tropomyosin receptor kinase A) pathway regulates the network of MMPs and CaM in triple-negative human breast carcinoma cells modulating the interaction of tumor cells with endothelial cells [279]. HRPAP20 (hormone-regulated proliferation-associated protein 20) is a CaM-binding proliferation-associated protein highly expressed in invasive breast cancer cells and is implicated in matrix metalloprotease-9 (MMP-9) secretion [280].…”
Section: Cam and Matrix Metalloproteasesmentioning
confidence: 99%
“…As a result, these pathways showed oncogenic effects by increasing cancer cell growth, proliferation, migration, epithelial-mesenchymal transition, and resistance to anoikis. These findings indicate that TrkB may be a useful target for therapeutic interventions for cancer cells (20)(21)(22)(23).…”
Section: Discussionmentioning
confidence: 80%